Pfizer Pharmaceuticals Korea signs co-promotion of ‘Prevenar 13’ with CKD

Published: 2018-05-24 10:58:46

Updated: 2018-05-24 10:58:46

Pfizer Pharmaceuticals Korea(CEO Dong-Wook Oh) and Chong Kun Dang(CEO Young-Joo Kim, CKD) singed a Korean co-promotion partnership agreement of ‘Prevenar®13’ adult products, a Pfizer Pharmaceuticals Korea’s pneumococcal protein conjugate vaccine, at The Westin Chosun Seoul on the 18^th.

The two companies concluded a distribution contract of the products last December, and extended the contact t...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.